Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1143studies shown

Showing 925-936 of 1,143

Drug study icon

CompletedNCT00206141

Seroquel in Depression in bipolarity Versus Lithium

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: Canada, Croatia, Estonia, ...
Sponsor: AstraZeneca
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00328978

Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Canada
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

CompletedNCT00234377

Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Canada, Finland, Germany, ...
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

TerminatedNCT00182533

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Anxiety, Depression, ...DrugFrom 18 Years to 70 Years

Countries: Canada
Sponsor: Hamilton Health Sciences Corporation
Condition: Anxiety, Depression, ...

Behavioral study icon

CompletedNCT02168166

Short-term Working Memory and Executive Training

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Queen's University
Condition: Schizophrenia

Behavioral study icon

WithdrawnNCT02553252

SKY Versus WLC in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDBehavioralFrom 18 Years to 75 Years

Countries: Canada
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition: PTSD

Behavioral study icon

TerminatedNCT03534583

SKY vs. HEP in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDBehavioralFrom 18 Years to 75 Years

Countries: Canada
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition: PTSD

Drug study icon

TerminatedNCT03948464

Slow-Release Oral Morphine for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionDrugFrom 19 Years to 65 Years

Countries: Canada
Sponsor: M. Eugenia Socias
Condition: Addiction

Behavioral study icon

CompletedNCT03672565

SMART ERP for the Behavioral Treatment of Youth With OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

OCDBehavioralFrom 7 Years to 19 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: OCD

Behavioral study icon

CompletedNCT07168954

Smart Light Therapy Glasses for Sleep and Mental Wellness

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionBehavioralOver 18 Years

Countries: Canada
Sponsor: University of Waterloo
Condition: Depression

Drug study icon

CompletedNCT05528718

SMILE study - Imaging Sub-Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionDrugFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Unity Health Toronto
Condition: Depression

Drug study icon

CompletedNCT00644969

Smoking Cessation Study for people with Schizophrenia or Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States, Canada
Sponsor: Pfizer
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.